The Company anticipates full-year 2025 total revenue of $732M, reflecting growth of approximately 20% compared to the full-year 2024. This includes surgical revenue of approximately $657M and approximately $75M of EOS revenue. The Company also expects adjusted EBITDA of approximately $75M, which will contribute to positive free cash flow for the full-year 2025.
Education
About Us
Working with TipRanks
Follow Us
1